Cellectar Biosciences, Inc. (CLRB) Financials

CLRB Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 36.6 million 6.8 million
March 31, 2026 11.1 million 6.4 million
Dec. 31, 2025 15.0 million 5.1 million
Sept. 30, 2025 14.6 million 5.2 million

CLRB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -6.0 million 428306
March 31, 2026 -4.8 million 451869
Dec. 31, 2025 -4.4 million 567788
Sept. 30, 2025 -4.3 million 567788

CLRB Net Income

No data available :(

CLRB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 34.0 million - 1.5 million
March 31, 2026 8.3 million - 1.5 million
Dec. 31, 2025 13.2 million - 409586
Sept. 30, 2025 12.6 million - 431929

CLRB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 12.2 million
March 31, 2026 4.2 million
Dec. 31, 2025 4.2 million
Sept. 30, 2025 3.2 million

CLRB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 4.6 million 2.6 million -
March 31, 2026 3375 3.0 million 2.8 million -
Dec. 31, 2025 5884 3.2 million 2.5 million -
Sept. 30, 2025 1 2.5 million 2.3 million -

CLRB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -110018
Dec. 31, 2025 - 49461
Sept. 30, 2025 - 52277

CLRB

Price: $1.18

52 week price:
1.18
20.59

Earnings Per Share: -2.21 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 27300

Ebitda: -3.4 million

Market Capitalization: 14.2 million

Links: